ALDR1EUR
Alder Biopharmaceuticals Inc
Clinical-stage biopharmaceutical company focused on migraine treatment development, acquired by H. Lundbeck A/S in October 2019
CUSIP: 014339105HealthcareUS1 holder
Total Value
$2.41M
Total Shares
189.5K
Net Share Change
+189.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Leon Cooperman
$2.41M189.5K sharesNEW